Cargando…
COVID-19: Cellular and Molecular Mechanisms of Brain Damage
The most common clinical manifestation of COVID-19 is bilateral pneumonia, a diffuse, alveolar injury with severe microangiopathy. Systemic infection is accompanied by an increase in circulating chemokines and interleukins in the blood, which penetrate the blood–brain barrier (BBB) and enter the bra...
Autor principal: | Gomazkov, O. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985060/ http://dx.doi.org/10.1134/S2079086422020037 |
Ejemplares similares
-
Damage to the Vascular Endothelium as a Leading Mechanism of COVID-19 Systemic Pathology
por: Gomazkov, O. A.
Publicado: (2021) -
Neurotropism as a Mechanism of the Damaging Action of Coronavirus
por: Gomazkov, O. A.
Publicado: (2022) -
Neuropilin Is a New Player in the Pathogenesis of COVID-19
por: Gomazkov, O. A.
Publicado: (2022) -
Cellular and Molecular Mechanisms in Neurodevelopmental Disorders and Brain Tumors
por: Costa, Mario, et al.
Publicado: (2023) -
Morphological, cellular, and molecular basis of brain infection in COVID-19 patients
por: Crunfli, Fernanda, et al.
Publicado: (2022)